Controlled cross-over study of prucalopride 2 mg daily or placebo in gastroparesis
(idiopathic or diabetic). Patients will be randomized to 4 week treatment with the first
regimen (double-blind), followed by a 2-week washout and 4 week treatment with the second
regimen in cross-over.